Description:
MetapneumovirusDFAReagentFeatures&Benefits:
NOTAVAILABLEFORSALEINTHEU.S.
TheD3 Ultra8DFA(directfluorescentantibody)RespiratoryVirusScreeningandIdentificationKitisintendedforthequalitativedetectionandidentificationofeightmajorrespiratoryviruses(influenzaA,influenzaB,respiratorysyncytialvirus(RSV),adenovirus,parainfluenza1,parainfluenza2andparainfluenza3viruses,andmetapneumovirus)inrespiratoryspecimens,byeitherdirectdetectionorcellculturemethod,byimmunofluorescenceusingfluoresceinatedmonoclonalantibodies(MAbs).Itisrecommendedthatspecimensfoundtobenegativeafterexaminationofthedirectspecimenresultbeconfirmedbycellculture.Negativeresultsdonotprecluderespiratoryvirusinfectionandshouldnotbeusedasthesolebasisfordiagnosis,treatmentorothermanagementdecisions.
ImprovelaboratoryworkflowandpatientcarewiththeD3Ultra8DFARespiratoryVirusScreeningandIdentificationKit.
- High-qualityantibodiesdevelopedattheQuidelHybridomafacility
- Forrapid,sensitiveandspecificscreeninganddefinitiveidentificationofInfluenzaA,InfluenzaB,Parainfluenza1,2,and3,RespiratorySyncytialVirusAdenovirusandMetapneumovirusfromdirectpatientspecimensorculture
- One-stepdirectdetectionkitwithafifteen-minuteincubation
- Improvesworkflowandlaboratorytimetoresult
美国 Quidel 公司（Quidel Corporation）成立于 1979 年，总部位于美国，连同其附属公司，从事传染病点保健和生殖与妇女健康的诊断解决方案的开发，制造及销售。公司现拥有员工共 322 人。是一家在美国纳斯达克上市的综合性临床诊断产品生产商和健康服务研发型企业,股票代码（Nasdaq: QDEL），其部分快速诊断产品占据美国主流市场。主要产品包括传染性疾病的诊断、生殖健康及孕期诊断、癌症辅助诊断、骨质疏松症辅助诊断及自身免疫疾病的辅助诊断，旗下品牌主要有：Metra， Quidel ， QuickVue ，QuickVue In-Line ，QuickVue Advance，QuickVue+，RapidVue 等。
